Iambic Therapeutics
✓ Verified
Healthcare AI
AI drug discovery
Series B2
Iambic Therapeutics is a clinical-stage life sciences and technology company that develops novel medicines using an AI-driven drug discovery platform. Its platform includes multimodal AI technologies such as Enchant and NeuralPlexer to support high-throughput experimental and computational workflows for small-molecule drug design, with an initial focus on oncology and broader therapeutic applications.
Company Details
- Website
- iambic.ai
- Headquarters
- San Diego, California, United States
- Founded
- 2019
- Funding
- $227M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring